Medable
-
Medable rolls out new decentralized trial software for speedier vaccine development
Medable recently launched a software solution to shorten the launch times for decentralized vaccine trials. The company says the software can reduce trial deployment timelines from more than 12 weeks on average to as short as five weeks.
-
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
-
Improving health equity through decentralized clinical trials
A recent webinar by Medable discussed steps it’s taking to improve clinical trial design through decentralized clinical trials
-
Google Cloud exec: Real-world data could eliminate the need for placebos in clinical trials
The speed of Covid-19 vaccine trials should inspire the pharmaceutical and medical device industries to accelerate its clinical testing, according to Shweta Maniar, Google Cloud’s director for healthcare and life sciences. She argued that harnessing real-world data will make faster clinical trials achievable for all therapeutics and devices, possibly even eliminating the need to recruit a placebo arm.
-
How to improve clinical trial recruitment and retention: Creating patient-centric studies
Join us tomorrow for a webinar sponsored by Medable as we explore challenges of drug innovation in the cardiometabolic space and how connected devices could make evidence collection less costly and more efficient to support regulatory evaluation and approvals.
-
Using smart patient-centered tech to reduce cost and time of clinical trials
A webinar sponsored by Medable will explore challenges of drug innovation in the cardiometabolic space and how connected devices could make evidence collection less costly and more efficient to support regulatory evaluation and approvals.
-
Consumer / Employer, Patient Engagement, Pharmacy
2 collaborations – CVS Health with Medable, and Thermo Fisher Scientific with Medidata Acorn AI – seek to improve clinical trials
CVS MinuteClinic providers will use Medable’s software platform to improve patient access, engagement and retention during clinical trials. Meanwhile, Thermo Fisher Scientific and Medidata Acorn AI announced a collaboration to develop an application that combines patient recruitment and site performance data for clinical trials.
-
Decentralized clinical trials platform Medable now valued at $2.1B
Medable recently raised $304 million, its fourth funding round in the past two years. The company’s software can be used to virtually consent patients into clinical trials and run telehealth visits as part of a trial.
-
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
-
Health IT, Startups, Health Tech
Investors pour $91M into growing clinical-trial software firm
The Covid-19 pandemic is altering behavior and fueling demand for remote technologies in clinical trials with Medable, a company in the clinical trial software space, looking to capitalize.
-
Decentralized clinical trials won’t slow down after Covid-19 pandemic ends
In a interview, an executive from Medable said patients will likely demand to have the choice of whether to show up at trial sites or participate in studies remotely. The Covid-19 pandemic has accelerated a trend toward decentralized trials that was already underway before it began.
-
How Covid-19 is accelerating adoption of decentralized clinical trials
Late last month, Medable and LabCorp CRO Covance signed a deal to accelerate adoption of decentralized trials, a trend that has been helped along as Covid-19 has created challenges to conducting trials dependent on traditional brick-and-mortar sites.
-
It’s not about what blockchain can do in healthcare, but what it’s already doing
A panel discussion at the upcoming MedCity INVEST meeting in Chicago will look at real-world applications of blockchain technology in healthcare and biopharma.
-
Blockchain becomes a ‘source of truth’ for biopharma
Although blockchain faces regulatory hurdles and skepticism, its potential as a shared, yet secure ledger system to improve the pharmaceutical supply chain integrity and clinical trials is making it attractive for experimentation and investment by drugmakers.